UNDERWRITING AGREEMENTUnderwriting Agreement • April 29th, 2020 • Chardan Healthcare Acquisition 2 Corp. • Blank checks • New York
The undersigned, Chardan Healthcare Acquisition 2 Corp., a Delaware corporation (“Company”), hereby confirms its agreement with Chardan Capital Markets, LLC (hereinafter referred to as “you,” “Chardan,” or as the “Representative”) and with the other underwriters named on Schedule A hereto for which you are acting as representative (the Representative and the other Underwriters being collectively referred to herein as the “Underwriters” or, individually, an “Underwriter”), as follows:
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • April 29th, 2020 • Chardan Healthcare Acquisition 2 Corp. • Blank checks • New York
THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is entered into as of the 23rd day of April, 2020, by and among Chardan Healthcare Acquisition 2 Corp., a Delaware corporation (the “Company”) and the undersigned parties listed under Investor on the signature page hereto (each, an “Investor” and collectively, the “Investors”).
FORM OF INDEMNITY AGREEMENTForm of Indemnity Agreement • April 29th, 2020 • Chardan Healthcare Acquisition 2 Corp. • Blank checks • Delaware
THIS INDEMNITY AGREEMENT (this “Agreement”) is made as of April 23, 2020, by and between Chardan Healthcare Acquisition 2 Corp., a Delaware corporation (the “Company”), and the undersigned (“Indemnitee”).
WARRANT AGREEMENTWarrant Agreement • April 29th, 2020 • Chardan Healthcare Acquisition 2 Corp. • Blank checks • New York
This Warrant Agreement (“Warrant Agreement”) is made as of April 23, 2020, by and between Chardan Healthcare Acquisition 2 Corp., a Delaware corporation (the “Company”), and Continental Stock Transfer & Trust Company (the “Warrant Agent”).
INVESTMENT MANAGEMENT TRUST AGREEMENTInvestment Management Trust Agreement • April 29th, 2020 • Chardan Healthcare Acquisition 2 Corp. • Blank checks • New York
This Agreement is made as of April 23, 2020 by and between Chardan Healthcare Acquisition 2 Corp. (the “Company”) and Continental Stock Transfer & Trust Company (“Trustee”).
Chardan Healthcare Acquisition 2 Corp.Chardan Healthcare Acquisition 2 Corp. • April 29th, 2020 • Blank checks • New York
This letter is being delivered to you in accordance with the Underwriting Agreement (the “Underwriting Agreement”) entered into by and between Chardan Healthcare Acquisition 2 Corp., a Delaware corporation (the “Company”) and Chardan Capital Markets, LLC, as representative (the “Representative”) of the Underwriters named in Schedule A thereto (the “Underwriters”), relating to an underwritten initial public offering (the “IPO”) of the Company’s units (the “Units”), each comprised of one share of Common Stock of the Company, par value $0.0001 per share (the “Common Stock”), and one warrant, with each warrant being exercisable to purchase one-half of one share of Common Stock at a price of $11.50 per full share (“Warrant”). Certain capitalized terms used herein are defined in paragraph 14 hereof.
STOCK ESCROW AGREEMENTStock Escrow Agreement • April 29th, 2020 • Chardan Healthcare Acquisition 2 Corp. • Blank checks • New York
This STOCK ESCROW AGREEMENT, dated as of April 23, 2020 (“Agreement”), by and among CHARDAN HEALTHCARE ACQUISITION 2 CORP., a Delaware corporation (“Company”) and the initial shareholders listed on the signature pages hereto (collectively, the “Initial Shareholders”) and CONTINENTAL STOCK TRANSFER & TRUST COMPANY, a New York corporation (“Escrow Agent”).
